Evidence map›Paper›PMID 41581101›Full record

ReviewMolecular biotechnology2026

Mesenchymal Stem/Stromal Cell-Free Therapies: Challenges and Opportunities.

Rebecca Shin-Yee Wong, Ee Wern Tan, Nancy Choon-Si Ng, Bey Hing Goh

Abstract readReview
In one paragraph

Review in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rebecca Shin-Yee WongDepartment of Medical Education, Sir Jeffrey Cheah Sunway Medical School, Faculty of Medical and Life Sciences, Sunway University, Bandar Sunway, Selangor, Malaysia.
Ee Wern TanSunway Biofunctional Molecule Discovery Centre, Faculty of Medical and Life Sciences, Sunway University, Bandar Sunway, Selangor, Malaysia.
Nancy Choon-Si NgDepartment of Medical Education, Sir Jeffrey Cheah Sunway Medical School, Faculty of Medical and Life Sciences, Sunway University, Bandar Sunway, Selangor, Malaysia.
Bey Hing GohSunway Biofunctional Molecule Discovery Centre, Faculty of Medical and Life Sciences, Sunway University, Bandar Sunway, Selangor, Malaysia. goh.beyhing@uts.edu.au.ORCID http://orcid.org/0000-0003-1006-3649

Funding

Sunway University GRTIN-ECR-SBMDC-05-2024Sunway University GRTIN-RAG(02)-DPSY-08-2024Sunway University GRTIN-RAG-SBMDC-05-2025Sunway University GRTIN-RAG-SBMDC-10-2024
6 · The paper itself

Abstract

Mesenchymal stem/stromal stem cells (MSCs) are promising therapeutic candidates in regenerative medicine and tissue engineering. MSCs have been applied in many medical conditions and their therapeutic effects, safety, and efficacy have been well established over the past few decades. However, several challenges exist when utilizing whole cells in research and the clinical settings. As a result, researchers have turned their attention to cell-free alternatives to overcome these challenges. One promising approach that can achieve the desired therapeutic effects without the need of whole-cell transplantation is the use of MSC-conditioned medium and secretome. This article gives an overview of the advantages of using cell-free strategies over cell-based strategies and the various types of cell-free alternatives available. It also critically examines the various cell-free approaches in MSC research and therapy and provides an in-depth discussion on the opportunities and challenges of using these strategies, with an emphasis on recent advances in the field.

Indexed as

Mesenchymal Stem CellsRegenerative MedicineAnimalsCell-Free SystemCulture Media, ConditionedExosomesHumansSecretomeTissue EngineeringCulture Media, ConditionedCell-free therapiesChallengesExosomesExtracellular vesiclesMesenchymal stem/stromal cellsOpportunitiesSecretome

Identifiers

PMID41581101
PMCPMC13279593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.